P. Astoul

L. Sakr, G. Tassi, V. Pinelli, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Malignant pleural mesothelioma.

M. Schlesser, P. Astoul, C. Boutin, 1998, The European respiratory journal.

Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging

J. Gouvernet, V. Ledoray, P. Astoul, 1993, Cancer.

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

F. Maldonado, L. Sakr, A. Loundou, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Intrapleural administration of interleukin‐2 for the treatment of patients with malignant pleural mesothelioma

P. Astoul, J. Viallat, C. Boutin, 1998, Cancer.

The role of thoracoscopy in the evaluation and management of pleural effusions

P. Astoul, C. Boutin, B. Seitz, 2007, Lung.

Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicine.

R. Loddenkemper, P. Astoul, C. Boutin, 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Feasibility of short term drainage for diagnostic thoracoscopy.

L. Greillier, P. Astoul, D. Breen, 2009, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.

P. Astoul, F. Rey, J. Viallat, 1996, Chest.

Thoracoscopy in the diagnosis and treatment of spontaneous pneumothorax.

P. Astoul, F. Rey, C. Boutin, 1995, Clinics in chest medicine.

Pleurodesis for recurrent malignant pleural effusions: the quest for the Holy Grail.

P. Astoul, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy.

F. Barlesi, R. Giudicelli, P. Fuentes, 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back

P. Astoul, 2020, Translational lung cancer research.

Lymphohistiocytoid Variant of Malignant Mesothelioma of the Pleura: A Series of 22 Cases

F. Galateau-Sallé, K. Kerr, G. Launoy, 2007, The American journal of surgical pathology.

Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies.

R. Giudicelli, P. Fuentes, C. Doddoli, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Gefitinib (ZD1839, Iressa®) in non‐small‐cell lung cancer: a review of clinical trials from a daily practice perspective

F. Barlesi, P. Villani, C. Doddoli, 2005, Fundamental & clinical pharmacology.

Non-small cell lung cancer-smokers or non-smokers, does it matter?

F. Barlesi, pierre-Marie Martin, I. Nanni-Metellus, 2009, Lung cancer.

One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.

F. Barlesi, R. Giudicelli, P. Fuentes, 2005, The Journal of thoracic and cardiovascular surgery.

Medical thoracoscopy. Technical details.

P. Astoul, C. Boutin, P. Mathur, 1995, Clinics in chest medicine.

Thoracoscopic talc poudrage decreases T-lymphocytes in the peripheral blood.

I. Kotsianidis, H. Papadaki, M. Froudarakis, 2007, Respiratory medicine.

Distribution of calibrated talc after intrapleural administration: an experimental study in rats.

P. Cau, A. Robaglia-Schlupp, P. Astoul, 2002, Chest.

Attributable risk in men in two French case-control studies on mesothelioma and asbestos

F. Galateau-Sallé, M. Goldberg, L. Salmi, 2010, European Journal of Epidemiology.

Intrapleural administration of lipoplatin in an animal model.

R. Guilhaumou, G. Karpathiou, M. Froudarakis, 2011, Lung cancer.

Intrapleural Administration of Pemetrexed: A Pharmacokinetic Study in an Animal Model

L. Greillier, N. Coltel, P. Astoul, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Natural-killer cell-mediated cytotoxicity of blood-lymphocytes from patients with malignant mesothelioma treated by intrapleural interleukin-2.

P. Astoul, C. Boutin, E. Nussbaum, 1995, International journal of oncology.

Diagnostic thoracoscopy.

P. Astoul, P. Astoul, C. Boutin, 1998, Clinics in chest medicine.

A patient-like human malignant pleural mesothelioma nude-mouse model.

H. Colt, R. Hoffman, X. Wang, 1996, Oncology reports.

Metastatic human pleural ovarian cancer model constructed by orthotopic implantation of fresh histologically-intact patient carcinoma in nude mice.

H. Colt, R. Hoffman, X. Wang, 1993, Anticancer research.

Editorial comment: Management of primary spontaneous pneumothorax: a plea for a mini-invasive approach.

P. Astoul, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Intrapleural immunotherapy with escalating doses of interleukin‐2 in metastatic pleural effusions

P. Astoul, F. Rey, J. Viallat, 1993, Cancer.

Talc for Pleurodesis: Hero or Villain?

P. Cau, A. Robaglia-Schlupp, P. Astoul, 2003 .

[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].

P. Astoul, C. Boutin, C. Frenay, 1999, Revue des maladies respiratoires.

Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.

F. Barlesi, A. Tasei, P. Astoul, 2006, Lung cancer.

Patient-like nude-mouse and scid-mouse models of human lung and pleural cancer (review).

X. Wang, P. Astoul, R. Hoffman, 1993, International journal of oncology.

Thoracoscopic findings in spontaneous pneumothorax in AIDS.

K. Kovitz, P. Astoul, P. Astoul, 1994, Chest.

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

F. Galateau-Sallé, V. Durieux, P. V. Van Schil, 2020, European Respiratory Journal.

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

F. Galateau-Sallé, V. Durieux, P. V. Van Schil, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

F. Galateau-Sallé, H. Dienemann, G. Hillerdal, 2009, European Respiratory Journal.

Malignant Pleural Mesothelioma: From the Bench to the Bedside

F. Galateau-Sallé, A. Scherpereel, P. Astoul, 2012, Respiration.

Mesothelioma and Asbestos-Related Pleural Diseases

L. Greillier, P. Astoul, 2008, Respiration.

Video-assisted thoracoscopic management of recurrent primary spontaneous pneumothorax after prior talc pleurodesis: a feasible, safe and efficient treatment option.

F. Barlesi, R. Giudicelli, P. Fuentes, 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[Diagnostic and therapeutic thoracoscopy].

P. Astoul, 1997, La Revue du praticien.

Alternating chemotherapy and accelerated split‐course irradiation in locally advanced nonsmall cell lung carcinoma

J. Gouvernet, P. Astoul, C. Boutin, 1999, Cancer.

Characterization of a French series of female cases of mesothelioma.

F. Galateau-Sallé, D. Luce, J. Pairon, 2013, American journal of industrial medicine.

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, International journal of cancer.

Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma

F. Galateau-Sallé, M. Goldberg, J. Pairon, 2014, Thorax.

Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature

M. Dixe, E. Sacadura-Leite, A. Sousa-Uva, 2023, Portuguese Journal of Public Health.

Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002).

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, American journal of industrial medicine.

[Cutaneous metastasis of pleural mesothelioma: two cases].

J. Grob, M. Richard, C. Gaudy-Marqueste, 2003, Annales de dermatologie et de venereologie.

Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.

P. Astoul, J. Viallat, C. Boutin, 1993, Chest.

Outbreak of carbapenem-resistant enterobacteria in a thoracic-oncology unit through clonal and plasmid-mediated transmission of the bla OXA-48 gene in Southern France

P. Brouqui, J. Rolain, N. Cassir, 2022, Frontiers in Cellular and Infection Microbiology.

[Quality of life: attitudes and perspectives of doctors in a thoracic oncology regional care network].

P. Auquier, F. Barlesi, C. Doddoli, 2006, Sante publique.

Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice.

R. Hoffman, Z. An, A. Moossa, 1996, Anticancer research.

Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.

H. Colt, R. Hoffman, X. Wang, 1996, Anticancer research.

Fatal pulmonary haemorrhage from a mycotic pulmonary artery aneurysm.

B. Chetaille, F. Barlesi, J. Gaubert, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management.

Pascal Thomas, F. Barlesi, A. Loundou, 2007, The Journal of thoracic and cardiovascular surgery.

[Pleural effusion. Diagnosis].

P. Astoul, A. Fraticelli, 2002, La Revue du praticien.

[Endobronchial tuberculosis simulating cancer].

P. Astoul, C. Boutin, B. Seitz, 1990, Revue des maladies respiratoires.

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy

F. Barlesi, C. Doddoli, J. Kleisbauer, 2004, British Journal of Cancer.

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

P. Astoul, C. Boutin, S. Kasseyet, 1999, Cancer.

[Hypersensitivity to carboplatin. An effect of generic drugs?].

F. Barlesi, A. Magnan, Y. Gernez, 2006, Revue des maladies respiratoires.

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

N. Le Stang, G. Zalcman, E. Bergot, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer].

M. Richard, F. Barlesi, C. Gaudy-Marqueste, 2007, Revue des maladies respiratoires.

Compensation of pleural mesothelioma in France: data from the French National Mesothelioma Surveillance Programme.

M. Goldberg, B. Clin, J. Pairon, 2013, American journal of industrial medicine.

Implantable access system for prolonged intrapleural immunotherapy.

J. Pasquier, P. Astoul, J. Viallat, 1994, The European respiratory journal.

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients].

E. Touboul, T. Molina, E. Lemarié, 2003, Bulletin du cancer.

[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].

E. Touboul, E. Lemarié, B. Milleron, 2001, Bulletin du cancer.

[Validation of the French version of the Princess Margaret Hospital Patient Satisfaction with their Doctor Questionnaire].

A. Loundou, P. Auquier, F. Barlesi, 2006, Revue des maladies respiratoires.

Diagnostic endoscopique du mésothéliome

P. Astoul, C. Boutin, C. Frenay, 1999 .

[Endoscopic diagnosis of mesothelioma].

P. Astoul, C. Boutin, C. Frenay, 1999, Revue des maladies respiratoires.

[Malignant mesothelioma: clinical and therapeutic study].

I. Monnet, P. Astoul, C. Boutin, 1999, Revue des maladies respiratoires.

[Acute respiratory distress syndrome following inhalation of barium sulfate].

B. Chetaille, L. Papazian, F. Barlesi, 2005, Revue des maladies respiratoires.

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

H. Dienemann, G. Hillerdal, R. Stahel, 2009, European Respiratory Journal.

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma

H. Dienemann, G. Hillerdal, R. Stahel, 2009 .

Official journal of the Turkish Thoracic Society

Ankara, J. E. Hansen, R. Casaburi, 2018 .

Official journal of the Turkish Thoracic Society

J. E. Hansen, Hasan S. Yamin, R. Casaburi, 2018 .

Pharmacokinetics of intrapleural recombinant interleukin‐2 in immunotherapy for malignant pleural effusion

P. Bertault-peres, A. Durand, P. Astoul, 1994, Cancer.

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

N. Le Stang, G. Zalcman, E. Bergot, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

F. Maldonado, L. Sakr, A. Loundou, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.